Technetium Tc 99M Etidronate

CHEMBL1200835 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
304.9 g/mol
LogP
Phase
4

Technetium Tc 99m etidronate is a bone-seeking radiopharmaceutical combining technetium-99m with etidronate bisphosphonate for skeletal scintigraphy. See technetium-etidronate for complete pharmacological details. It localizes to areas of increased bone turnover for detection of metastatic and metabolic bone disease.

Molecular Weight

304.9300 g/mol

TPSA

135.00 Ų

Mechanism of Action

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanism

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

SMILES

CC(O)(P(=O)(O)O)P(=O)(O)O.[99Tc]

InChI

InChI=1S/C2H8O7P2.Tc/c1-2(3,10(4,5)6)11(7,8)9;/h3H,1H3,(H2,4,5,6)(H2,7,8,9);/i;1+1

Molecular Formula

C2H8O7P2Tc

HBD / HBA

5 / 7

Rotatable Bonds

2

Heavy Atoms

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

Technetium Tc 99m etidronate is a bone-seeking radiopharmaceutical combining technetium-99m with etidronate bisphosphonate for skeletal scintigraphy. See technetium-etidronate for complete pharmacological details. It localizes to areas of increased bone turnover for detection of metastatic and metabolic bone disease.

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Yes, Technetium Tc 99M Etidronate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200835. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 123827. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.